Published August 21, 2025 | Version v2

Novel (d)PCR assays for influenza A(H5Nx) viruses clade 2.3.4.4b surveillance

  • 1. European Commission, Joint Research Centre (JRC), Geel, Belgium
  • 2. Seidor Italy S.r.l., Milan, Italy
  • 3. EU/National Reference Laboratory for Avian Influenza and Newcastle Disease, Istituto Zooprofilattico Sperimentale delle Venezie (IZSVe), Legnaro, Italy
  • 4. European Commission, Joint Research Centre (JRC), Ispra, Italy
  • 5. Avian Virology and Immunology, Sciensano, Brussels, Belgium
  • 6. European Union Reference Laboratory for Avian Influenza and Newcastle Disease, Istituto Zooprofilattico Sperimentale delle Venezie (IZSVe), Legnaro, Italy
  • 7. National Center for Water Safety (CeNSiA), Istituto Superiore di Sanità, Rome, Italy
  • 8. Department of Food Safety, Nutrition and Veterinary Public Health, Istituto Superiore di Sanità, Rome, Italy

Description

BACKGROUND
Since March 2024, cases of highly pathogenic avian influenza (HPAI) caused by A(H5N1) virus of clade 2.3.4.4b have been reported in dairy cattle in the United States, followed by spillover to avian and other mammalian species including humans. Although human-to-human transmission has not been reported, the virus's ability to infect mammals and potential of adaptation raise public health concerns, necessitating enhanced monitoring and preparedness.
AIM
We aimed to develop digital RT-PCR assays to detect and quantify influenza A(H5N1) 2.3.4.4b viruses in biological and environmental samples.
METHODS
We developed two digital RT-PCR assays targeting the matrix protein (JRC-MP) and haemagglutinin (JRC-HA) genes of A(H5N1) 2.3.4.4b viruses. After in silico assessment of inclusivity and exclusivity, we evaluated the assays’ performance using RNAs from influenza A(H5N1) viruses isolated from infected animal specimens, in an inter-laboratory exercise with diverse target and non-target isolates, and on wastewater samples either negative or spiked with A(H5N1) 2.3.4.4b RNA.
RESULTS
The JRC-MP assay detects influenza A viruses of different subtypes and origins, while the JRC-HA assay specifically detects HPAI A(H5Nx) 2.3.4.4b strains. The assays demonstrated high sensitivity, showing consistent results in the inter-laboratory exercise. They also detected target RNAs in wastewater samples with high accuracy, despite background components, supporting potential use in wastewater surveillance programmes.
CONCLUSIONS
Aligned with One Health strategies for zoonotic avian influenza surveillance, we propose the combined use of these two assays for the rapid and sensitive detection of influenza A(H5Nx) 2.3.4.4b in biological and environmental samples to enhance monitoring and outbreak control measures.

Notes (English)

DECLARATION The scientific output expressed does not imply a policy position of the European Commission. Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use that might be made of this publication.

Files

H5N1_V2.pdf

Files (34.1 kB)

Name Size Download all
md5:3f10bb054b35e31761dbb4d3f9d7afe9
34.1 kB Preview Download

Additional details

Dates

Created
2024-05-30
Accepted
2025-06-26